Stocks · Health care · Pharmaceutical Preparations

Kailera Therapeutics, Inc.

KLRA
United States Fiscal year ends December CIK 0002096997
$11.61 +16.10% Close, 9 Oct 2026
Price $11.61 −44.74% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 17 Apr 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Financial statements

Nothing filed here yet

No statements have been read for KLRA. They arrive with the nightly refresh; a company joins the screen the first time one is.